Glioblastoma and other malignant gliomas: a clinical review, JAMA, vol.310, issue.17, pp.1842-1850, 2013. ,
Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial, J Clin Oncol, vol.31, issue.32, pp.4085-4091, 2013. ,
Emerging therapies for glioblastoma, JAMA Neurol, vol.71, issue.11, pp.1437-1444, 2014. ,
Cancer epigenetics: from mechanism to therapy, Cell, vol.150, issue.1, pp.12-27, 2012. ,
A decade of exploring the cancer epigenome -biological and translational implications, Nat Rev Cancer, vol.11, issue.10, pp.726-734, 2011. ,
Genome-wide epigenetic regulation of miRNAs in cancer, Cancer Res, vol.73, issue.2, pp.473-477, 2013. ,
A microRNA DNA methylation signature for human cancer metastasis, Proc Natl Acad Sci, vol.105, issue.36, pp.13556-13561, 2008. ,
Glioma CpG Island Methylator Phenotype (G-CIMP): Biological and Clinical Implications, Neuro Oncol, vol.20, issue.5, pp.608-620, 2017. ,
A novel prognostic six-CpG signature in glioblastomas, CNS Neurosci Ther, vol.24, pp.167-177, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01711026
The somatic genomic landscape of glioblastoma, Cell, vol.155, issue.2, pp.462-477, 2013. ,
Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma, Genome Biol, vol.16, p.16, 2015. ,
Molecular profiling reveals biologically discrete subsets and pathwaBarthelys of progression in diffuse glioma, Cell, vol.164, issue.3, pp.550-563, 2016. ,
MGMT-STP27 methylation status as predictive marker for response to PCV in anaplastic Oligodendrogliomas and Oligoastrocytomas. A report from EORTC study 26951, Clin Cancer Res, vol.19, issue.19, pp.5513-5522, 2013. ,
Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma, Cancer Cell, vol.17, issue.5, pp.510-522, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-01201573
MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status, Acta Neuropathol, vol.124, issue.4, pp.547-560, 2012. ,
Adjusting batch effects in microarray expression data using empirical Bayes methods, Biostatistics, vol.8, issue.1, pp.118-127, 2007. ,
Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis, BMC Bioinformatics, vol.11, p.587, 2010. ,
Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment, Blood, vol.118, issue.5, pp.1350-1358, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00743991
Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes, N Engl J Med, vol.350, issue.18, pp.1828-1837, 2004. ,
Gene set enrichment analysis: a knowledge-based approach for interpreting genomewide expression profiles, Proc Natl Acad Sci, vol.102, issue.43, pp.15545-15550, 2005. ,
Common features of microRNA target prediction tools, Frontiers in genetics, vol.5, p.23, 2014. ,
PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools, Nucleic Acids Res, vol.47, issue.D1, pp.419-426, 2019. ,
CluePedia Cytoscape plugin: pathway insights using integrated experimental and in silico data, Bioinformatics, vol.29, issue.5, pp.661-663, 2013. ,
ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks, Bioinformatics, vol.25, issue.8, pp.1091-1093, 2009. ,
CpG methylation of transcription factor 4 in gastric carcinoma, Ann Surg Oncol, vol.17, issue.12, pp.3344-3353, 2010. ,
Wound-healing assay, Methods Mol Biol, vol.294, pp.23-29, 2005. ,
Resistance to antiangiogenic therapy, Curr Neurol Neurosci Rep, vol.14, issue.5, p.443, 2014. ,
Bevacizumab and glioblastoma: scientific review, newly reported updates, and ongoing controversies, Cancer, vol.121, issue.7, pp.997-1007, 2015. ,
The role of bevacizumab in the treatment of glioblastoma, J Neurooncol, vol.133, issue.3, pp.455-467, 2017. ,
miRNA1284 inhibits cell growth and induces apoptosis of lung cancer cells, Mol Med Rep, vol.16, issue.3, pp.3049-3054, 2017. ,
MiR-1284 modulates multidrug resistance of gastric cancer cells by targeting EIF4A1, Oncol Rep, vol.35, issue.5, pp.2583-2591, 2016. ,
MicroRNA-1284 inhibits cell viability and induces apoptosis of ovarian cancer cell line OVCAR3, Oncol Res, vol.24, issue.6, pp.429-435, 2016. ,
Analysis of bladder cancer tumor CpG methylation and gene expression within The Cancer Genome Atlas identifies GRIA1 as a prognostic biomarker for basal-like bladder cancer, Am J Cancer Res, vol.7, issue.9, pp.1850-1862, 2017. ,
Gene body methylation can alter gene expression and is a therapeutic target in cancer, Cancer Cell, vol.26, issue.4, pp.577-590, 2014. ,
Upregulation of miR-132 expression in glioma and its clinical significance, Tumour Biol, vol.35, issue.12, pp.12299-12304, 2014. ,
Correlation of MicroRNA 132 up-regulation with an unfavorable clinical outcome in patients with primary glioblastoma multiforme treated with radiotherapy plus concomitant and adjuvant temozolomide chemotherapy, Transl Oncol, vol.6, issue.6, pp.742-748, 2013. ,
A conserved gene structure and expression regulation of miR-433 and miR-127 in mammals, PLoS One, vol.4, issue.11, p.7829, 2009. ,
MicroRNA-127-3p promotes glioblastoma cell migration and invasion by targeting the tumor-suppressor gene SEPT7, Oncol Rep, vol.31, issue.5, pp.2261-2269, 2014. ,
A catalogue of glioblastoma and brain MicroRNAs identified by deep sequencing, OMICS, vol.16, issue.12, pp.690-699, 2012. ,
MiR-433-3p suppresses cell growth and enhances chemosensitivity by targeting CREB in human glioma, Oncotarget, vol.8, issue.3, pp.5057-5068, 2017. ,